deep research index

what are the most promising anti-aging interventions currently in human clinical trials? compare rap...

research prompt

what are the most promising anti-aging interventions currently in human clinical trials? compare rapamycin, metformin, NAD+ precursors, and senolytics.

date
Feb 16, 2026
blind battlewinner: geminiOpenAIPerplexityGemini
metricOpenAIPerplexityGemini
formatproseproseprose
word count1,3537,1702,629
sources42600
processing time569s154s1s
has imagesnonono
has tablesnonono
citation style———

Gemini

prose • 2,629 words
# Current Status of Anti-Aging Interventions in Human Clinical Trials: A Comparative Analysis of Rapamycin, Metformin, NAD+ Precursors, and Senolytics ## Executive Summary The landscape of geroscience has shifted from preclinical speculation to rigorous human clinical validation. As of late 2024 and through 2025, the field has witnessed pivotal data readouts concerning four major classes of geroprotectors: mTOR inhibitors (rapamycin), biguanides (metformin), NAD+ precursors, and senolytics. Ke...

OpenAI

prose • 1,353 words
# Anti‐Aging Interventions in Clinical Trials Researchers have targeted several existing drugs and compounds for “anti‐aging” effects. Four leading approaches in human trials are **rapamycin (mTOR inhibitors)**, **metformin**, **NAD⁺ precursors** (e.g. nicotinamide riboside (NR) or NMN), and **senolytics**. All show promise in animal models, but human data are preliminary and mixed. Below we summarize each approach, its rationale, and recent trial findings. ## Rapamycin (mTOR Inhibitors) R...

Perplexity

prose • 7,170 words
# Promising Anti-Aging Interventions in Human Clinical Trials: A Comprehensive Analysis of Rapamycin, Metformin, NAD+ Precursors, and Senolytics The past decade has witnessed a remarkable transformation in aging research, with an increasing number of pharmacological interventions transitioning from preclinical validation to human clinical trials[1][4][31]. Among the most scientifically validated candidates are rapamycin, metformin, NAD+ precursor compounds, and senolytic drugs—each representing...

Gemini

prose • 2,629 words
# Current Status of Anti-Aging Interventions in Human Clinical Trials: A Comparative Analysis of Rapamycin, Metformin, NAD+ Precursors, and Senolytics ## Executive Summary The landscape of geroscience has shifted from preclinical speculation to rigorous human clinical validation. As of late 2024 and through 2025, the field has witnessed pivotal data readouts concerning four major classes of geroprotectors: mTOR inhibitors (rapamycin), biguanides (metformin), NAD+ precursors, and senolytics. Ke...

ai-generated content. verify independently. preserved in the museum of queries.